Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15545982 | 0.77 | GCGR (0.30) | — | |
| SCHEMBL24832731 | 0.69 | — | — | |
| SCHEMBL2600739 | 0.69 | GCGR (0.30) | — | |
| SCHEMBL20787066 | 0.69 | ALDH1A1 (0.41) | — | |
| SCHEMBL9832575 | 0.67 | — | — | |
| SCHEMBL13259633 | 0.67 | SRC (0.35) | — | |
| SCHEMBL13438489 | 0.67 | KDM4E (0.30) | — | |
| SCHEMBL10414406 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL9833404 | 0.65 | — | — | |
| SCHEMBL18999980 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10781177-B2 | Pyridine compound and use thereof | NIPPON SODA CO., LTD. (JP) | 2020-09-22 | — | — | US | disclosed |
| US-10781177-B2 | Pyridine compound and use thereof | NIPPON SODA CO., LTD. (JP) | 2020-09-22 | — | — | US | disclosed |
| US-20190071403-A1 | PYRIDINE COMPOUND AND USE THEREOF | NIPPON SODA CO., LTD. (JP) | 2019-03-07 | — | — | US | disclosed |
| US-20190071403-A1 | PYRIDINE COMPOUND AND USE THEREOF | NIPPON SODA CO., LTD. (JP) | 2019-03-07 | — | — | US | disclosed |
| EP-3428151-A1 | PYRIDINE COMPOUND AND USE THEREOF | Nippon Soda Co., Ltd. (JP) | 2019-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10781177-B2 | Pyridine compound and use thereof | NOX1, NOXO1, NOX4 | GABRA1 4300/4885GABRB1 4496/4885GABRB2 4675/4885 |
| US-20190071403-A1 | PYRIDINE COMPOUND AND USE THEREOF | NOX1, NOXO1, NOX4 | GABRA1 4300/4885GABRB1 4496/4885GABRB2 4675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.